Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference
Rhea-AI Summary
Avanos Medical (NYSE: AVNS) has announced its participation in the Stifel 2024 Healthcare Conference. Michael Greiner, interim CEO, will engage in an analyst-led fireside chat at the Lotte New York Palace on Tuesday, Nov. 19 at 3:35 p.m. ET. The presentation will be accessible via webcast on the company's website's Investors section, where it will also be archived for future reference.
Positive
- None.
Negative
- None.
News Market Reaction – AVNS
In the trading session that priced this news, AVNS declined 3.82%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.
About Avanos Medical, Inc.
Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-stifel-2024-healthcare-conference-302302998.html
SOURCE Avanos Medical